New Premium-grade Bioactive Proteins for Drug Discovery, Development and Manufacturing Announced
Nov 04 2020
Abcam’s new premium-grade bioactive proteins are highly-active growth factors and cytokines manufactured and designed to meet the specific needs of cell culture, including cell and gene therapy and regenerative medicine.
Sourcing high-quality proteins with batch-to-batch consistency can be a challenge, as endotoxin levels and/or non-native protein conformations and post-translational modifications can affect safety and performance.
Abcam’s new premium-grade proteins are manufactured in mammalian cell lines under animal-free conditions limiting endotoxins to ultra-low levels (< 5 EU/mg). The use of mammalian cell lines produces proteins with the desired conformation and correct post-translational modifications for optimal bioactivity. They resemble the proteins’ native state, helping to ensure a safe and consistent outcome during drug discovery, development and manufacturing.
Developed by a team of industry-expert protein scientists, each batch is validated using state-of-the-art technology to ensure consistent quality regarding integrity, purity, concentration, mono-dispersity and correct folding.
Abcam can also design, manufacture and validate proteins to custom needs and specifications. As a supplier of proteins for a broad range of applications, Abcam provides a comprehensive range of bioactive and research-grade proteins that enable additional cost-effective quality solutions.
Abcam’s premium-grade bioactive proteins provide: superb bioactivity; ultra-low endotoxin levels, < 5 EU/mg; native post-translational modifications; > 95% purity; carrier-free, tag-free; manufactured under ISO9001; batch-to-batch consistency monitored by sophisticated quality control, addressing identity, integrity, purity, concentration, folding and aggregation using methods such as LCMS, light scattering and thermal denaturation; premium protein product certificate of analysis provided.
More information online
In This Edition Chromatography Optimising Viral Vector Purification Strategies with Multimodal Chromatography Key UHPLC Characteristics Required for High throughput LC-MS New Low Volum...
View all digital editions
Dec 20 2022 Shanghai, China & Online 21 November 2022 to 13 January 2023
Jan 25 2023 Tokyo, Japan
Jan 30 2023 Dubai, UAE
Feb 01 2023 Tokyo, Japan
Feb 06 2023 Dubai, UAE